Search

Financial results - NEVRAX MED S.R.L.

0.00
Financial Summary - Nevrax Med S.r.l.
Unique identification code: 41856621
Registration number: J01/1711/2019
Nace: 8622
Sales - Ron
22.781
Net Profit - Ron
18.728
Employees
Open Account
Company Nevrax Med S.r.l. with Fiscal Code 41856621 recorded a turnover of 2024 of 22.781, with a net profit of 18.728 and having an average number of employees of - . The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Nevrax Med S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 117 7.384 14.445 20.354 19.479 22.781
Total Income - EUR - - - - 117 7.384 14.445 20.354 19.479 22.781
Total Expenses - EUR - - - - 8 352 368 272 452 571
Gross Profit/Loss - EUR - - - - 109 7.032 14.077 20.082 19.027 22.211
Net Profit/Loss - EUR - - - - 105 6.825 13.644 19.472 16.044 18.728
Employees - - - - 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 17.6%, from 19.479 euro in the year 2023, to 22.781 euro in 2024. The Net Profit increased by 2.774 euro, from 16.044 euro in 2023, to 18.728 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Nevrax Med S.r.l.

Rating financiar

Financial Rating -
NEVRAX MED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Nevrax Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nevrax Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Nevrax Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nevrax Med S.r.l. - CUI 41856621

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 0 0 0 0 0 0
Current Assets - - - - 151 7.051 14.895 19.659 16.982 19.849
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 0 1.180 0 3.865 5.432 1.845
Cash - - - - 151 5.871 14.895 15.794 11.549 18.004
Shareholders Funds - - - - 148 6.970 14.799 19.520 16.092 18.776
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 4 81 96 139 889 1.073
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 19.849 euro in 2024 which includes Inventories of 0 euro, Receivables of 1.845 euro and cash availability of 18.004 euro.
The company's Equity was valued at 18.776 euro, while total Liabilities amounted to 1.073 euro. Equity increased by 2.774 euro, from 16.092 euro in 2023, to 18.776 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Nevrax Med S.r.l.

Comments - Nevrax Med S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.